|
|
| CAS番号. | 1089283-49-7 |
| 化学名: | |
| 别名: | |
| 英語化学名: | GSK1904529A |
| 英語别名: | GSK 4529;GSK1904529A;GSK1904529A : IGF-IR, IGF-IIR inhibitor;N-(2,6-difluorophenyl)-5-(3-(2-(5-ethyl-2-methoxy-4-(4-(4-(methylsulfonyl)piperazin-1-yl)piperidin-1-yl)phenylamino)pyrimidin-4-yl)H-imidazo[1,2-a]pyridin-2-yl)-2-methoxybenzamide;N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide;N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide GSK 1904529A |
| CBNumber: | CB92501005 |
| 分子式: | C44H47F2N9O5S |
| 分子量: | 0 |
| MOL File: | Mol file |
|
|
|
|
GSK1904529A 化学特性,用途語,生産方法 |
使用
A selective inhibitor of IGF-1R and IR with IC50s of 27 nM and 25 nM, respectively. |
|
|
| GSK1904529A 上流と下流の製品情報 |
原材料
|
準備製品
|
| GSK1904529A 生産企業 Global( 39)Suppliers |
| 名前 | 電話番号 | ファックス番号 | 電子メール | 国籍 | 製品カタログ | 優位度 |
|
Shanghai Boyle Chemical Co., Ltd.
| Mr Qiu 86-21-50182298(Domestic Market)Miss Xu 86-21-50180596(Abroad Market) | 86-21-57758967 | sales@boylechem.com | CHINA |
5604
|
55
|
|
Chembest Research Laboratories Limited
| +86(0)21-20908456 | +86(0)21-58180499 | sales@biochembest.com | CHINA |
6000
|
61
|
|
JinYan Chemicals(ShangHai) Co.,Ltd.
| 13817811078,021-50426030 | 86-021-50426522,50426273 | sales@jingyan-chemical.com | CHINA |
10108
|
60
|
|
Jinan Trio PharmaTech Co., Ltd.
| +86 (531) 88811793；+86 (531) 88811783;+(0)18854807083; | +86 (531) 55696010 QQ981200479 | sales@trio-pharmatech.com (International market);trio@trio-pharmatech.com(Domestic market) | CHINA |
1779
|
62
|
|
ShangHai Biochempartner Co.,Ltd
| +86 13818785766，400-021-9906 | | gaoqing@biochempartner.com | CHINA |
1167
|
62
|
|
China Langchem Inc.
| 0086-21-58956006,021-58950017;021-38701807 | 0086-21-58956100 | sales@langchem.com | CHINA |
11187
|
57
|
|
BOC Sciences
| 1-631-504-6093 | 1-631-614-7828 | sales@bocsci.com | USA |
9972
|
65
|
|
Shanghai PharmaChem CO.,Ltd.
| 13621878384 | 13621878384 | wm_pharchem@163.com | CHINA |
20
|
60
|
|
T&W GROUP
| +86-21-61551611, 61551413, 61551420, 61551610 | +86-21-50676805 | contact@trustwe.com | CHINA |
13395
|
58
|
|
NCE Biomedical Co.,Ltd.
| 4000-027-021 |24 hour enquiry :+86-13986109188 |English:+86-15623472865 |Japanese:+81-08033611988 | +86-27-87599188 | sales@ncebiomed.com | CHINA |
1503
|
55
|
|
|
|
|
|
1089283-49-7
GSK1904529A
GSK1904529A : IGF-IR, IGF-IIR inhibitor
N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide
GSK 4529
N-(2,6-difluorophenyl)-5-(3-(2-(5-ethyl-2-methoxy-4-(4-(4-(methylsulfonyl)piperazin-1-yl)piperidin-1-yl)phenylamino)pyrimidin-4-yl)H-imidazo[1,2-a]pyridin-2-yl)-2-methoxybenzamide
N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide GSK 1904529A
|